These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3081784)

  • 1. Agranulocytosis associated with the use of amodiaquine for malaria prophylaxis.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):165-6. PubMed ID: 3081784
    [No Abstract]   [Full Text] [Related]  

  • 2. Malaria prophylaxis for Canadian travellers.
    CMAJ; 1985 Nov; 133(10):1024-6. PubMed ID: 3904965
    [No Abstract]   [Full Text] [Related]  

  • 3. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
    Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
    Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfadoxine-pyrimethamine plus chloroquine or amodiaquine for uncomplicated falciparum malaria: a randomized, multisite trial to guide national policy in Uganda.
    Bakyaita N; Dorsey G; Yeka A; Banek K; Staedke SG; Kamya MR; Talisuna A; Kironde F; Nsobya S; Kilian A; Reingold A; Rosenthal PJ; Wabwire-Mangen F
    Am J Trop Med Hyg; 2005 May; 72(5):573-80. PubMed ID: 15891132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serious reactions during malaria prophylaxis with pyrimethamine-sulfadoxine.
    Olsen VV; Loft S; Christensen KD
    Lancet; 1982 Oct; 2(8305):994. PubMed ID: 6127497
    [No Abstract]   [Full Text] [Related]  

  • 7. Adverse reactions to Fansidar and updated recommendations for its use in the prevention of malaria.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Jan; 33(51-52):713-4. PubMed ID: 3917533
    [No Abstract]   [Full Text] [Related]  

  • 8. Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria.
    Hatton CS; Peto TE; Bunch C; Pasvol G; Russell SJ; Singer CR; Edwards G; Winstanley P
    Lancet; 1986 Feb; 1(8478):411-4. PubMed ID: 2868340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Amodiaquine-induced agranulocytosis in malaria prevention: demonstration of an amodiaquine-induced cytotoxic antibody against granulocytes].
    Schulthess HK; von Felten A; Gmür J; Neftel K
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1912-3. PubMed ID: 6665534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amodiaquine, sulfadoxine-pyrimethamine, and combination therapy for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Lankoande M; Ouedraogo JB; Rosenthal PJ
    Am J Trop Med Hyg; 2005 Nov; 73(5):826-32. PubMed ID: 16282288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fansidar for malaria prophylaxis.
    Kissane D
    Aust Fam Physician; 1985 Aug; 14(8):738. PubMed ID: 3901990
    [No Abstract]   [Full Text] [Related]  

  • 12. Amodiaquine-induced agranulocytosis: drug inhibition of myeloid colonies in the presence of patient's serum.
    Douer D; Schwartz E; Shaked N; Ramot B
    Isr J Med Sci; 1985 Apr; 21(4):331-4. PubMed ID: 3997496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Stevens-Johnson syndrome and granulopenia induced by sulfadoxine-pyrimethamine (Fansidar)].
    Ligthelm RJ; van Zwienen J; Stuiver PC; Djajadiningrat AP
    Ned Tijdschr Geneeskd; 1983 Sep; 127(38):1735-7. PubMed ID: 6633717
    [No Abstract]   [Full Text] [Related]  

  • 14. Tolerability of amodiaquine and sulphadoxine-pyrimethamine, alone or in combination for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan adults.
    Fanello CI; Karema C; van Doren W; Rwagacondo CE; D'Alessandro U
    Trop Med Int Health; 2006 May; 11(5):589-96. PubMed ID: 16640610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of the amodiaquine+sulfadoxine-pyrimethamine combination and of chloroquine for the treatment of malaria in Córdoba, Colombia, 2006].
    Pérez MA; Cortés LJ; Guerra AP; Knudson A; Usta C; Nicholls RS
    Biomedica; 2008 Mar; 28(1):148-59. PubMed ID: 18645670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, chloroquine-sulfadoxine-pyrimethamine combination, and amodiaquine-sulfadoxine-pyrimethamine combination in Central African children with noncomplicated malaria.
    Menard D; Madji N; Manirakiza A; Djalle D; Koula MR; Talarmin A
    Am J Trop Med Hyg; 2005 May; 72(5):581-5. PubMed ID: 15940847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant Plasmodium falciparum.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Apr; 34(14):185-90, 195. PubMed ID: 3156271
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon.
    Basco LK; Same-Ekobo A; Ngane VF; Ndounga M; Metoh T; Ringwald P; Soula G
    Bull World Health Organ; 2002; 80(7):538-45. PubMed ID: 12163917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of sulfadoxine-pyrimethamine, amodiaquine, and sulfadoxine-pyrimethamine-amodiaquine combination for the treatment of uncomplicated falciparum malaria in the urban and suburban areas of Brazzaville (Congo).
    Ndounga M; Mayengue PI; Tahar R; Casimiro PN; Matondo Maya DW; Miakassissa-Mpassi V; Malonga DA; Nsonde-Ntandou F; Mallanda G; Ringwald P; Basco LK; Ntoumi F
    Acta Trop; 2007 Sep; 103(3):163-71. PubMed ID: 17645863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, safety, and selection of molecular markers of drug resistance by two ACTs in Mali.
    Djimdé AA; Fofana B; Sagara I; Sidibe B; Toure S; Dembele D; Dama S; Ouologuem D; Dicko A; Doumbo OK
    Am J Trop Med Hyg; 2008 Mar; 78(3):455-61. PubMed ID: 18337343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.